I received my Bachelor of Arts degree in Greek in 2004 from the College of William and Mary. In 2004, I moved to Gainesville, FL to pursue a Doctor of Pharmacy at the University of Florida, which I completed in 2008. I remained at the University of Florida to pursue a Doctor of Philosophy in Clinical Pharmaceutical Sciences. My graduate work focused on the pharmacogenomics of adverse metabolic effects of antihypertensives under the mentorship of Drs. Julie Johnson and Rhonda Cooper-DeHoff. In August 2012, I began a research fellowship in the department of Clinical Pharmacology at Vanderbilt University under the mentorship of Dr. Dan Roden. At Vanderbilt, my research studies focused on cardiovascular pharmacogenetics and I served as the Jason D. Morrow Chief Fellow for the Division of Clinical Pharmacology. In September 2016, I joined the faculty at the University of Arizona College of Pharmacy in the Department of Pharmacy Practice and Science. Since graduating from pharmacy school, I have continuously practiced pharmacy in hospital and retail settings and maintained board certification in pharmacotherapy. My long term research objective is to determine biomarkers for serious adverse reactions, especially heparin-induced thrombocytopenia, and translate this knowledge into personalized drug treatment in patients. I am an author on seventeen peer-reviewed manuscripts and twenty three abstracts presented at national and international meetings. I am active in multiple professional societies including the American Heart Association, American Society for Clinical Pharmacology and Therapeutics, and the American College of Clinical Pharmacy. I have been awarded a Scientist Development Grant from the American Heart Association and a Futures Grant from the American College of Clinical Pharmacy Research Institute.